Tatlı, Ö. Et Al. 2023. A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab. HELIYON , vol.9, no.11 , 1-16.

Tatlı, Ö., Tahir Turanlı, E., & Dinler Doğanay, G., (2023). A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab. HELIYON , vol.9, no.11, 1-16.

Tatlı, Özge, EDA TAHİR TURANLI, And Gizem Dinler Doğanay. "A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab," HELIYON , vol.9, no.11, 1-16, 2023

Tatlı, Özge Et Al. "A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab." HELIYON , vol.9, no.11, pp.1-16, 2023

Tatlı, Ö. Tahir Turanlı, E. And Dinler Doğanay, G. (2023) . "A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab." HELIYON , vol.9, no.11, pp.1-16.

@article{article, author={Özge Tatlı Et Al. }, title={A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab}, journal={HELIYON}, year=2023, pages={1-16} }